# KM05 Preference Label 2 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task b0tza971, batch 20260609_045644).
Current status: DRAFT for platform entry.

Studio-selected pair:
- Transcript A = 0.950, 48 steps, 12m 10s.
- Transcript B = 0.350, 48 steps, 10m 0s. (Same trajectory Studio served as PL1's B; the comparison differs because the A differs - 0.95 clean hold here vs PL1's 0.68 sequencing hold.)
- Bundle IDs not shown in the UI capture; record from the download icons on submit.

Both deliverables read in full against golden-KM05-v4.docx and grader-guidelines-task5-v4.txt before labeling.

KEY FINDING: The decider is plan item 1, the cardiorenal regimen. A is a clean catch: it holds all four held agents (sacubitril/valsartan, spironolactone, empagliflozin, furosemide), resumes none of them at this visit, and sets up a staged, one-agent-at-a-time restart gated on today's labs and orthostatics and coordinated with cardiology and nephrology. B advances the regimen, resuming the held agents at this visit gated on today's labs and adding spironolactone and empagliflozin to the advance - the premature restart the chart forbids. Both make the same correct moves elsewhere (patient-reported home BP, metformin held, no numeric prednisone dose, immunizations reframed to review-and-verify, endocrinology follow-up added, OT medication-safety plan). A resists the central trap; B falls for it.

VERDICT: A3 (A much better). Button = A++ (two plus signs).

## Justification

Preferred output: A

Both notes are thorough, source-grounded, and well-formatted, and both correctly treat the home blood pressure as patient report, hold metformin, assert no numeric prednisone dose, reframe the unsupported immunization claim to review-and-verify, add the endocrinology follow-up, and build the OT-based medication-safety plan. The deciding factor is plan item 1, the cardiorenal regimen, which is the task's central axis. A keeps all four held agents held and resumes none at this visit, setting up a staged, one-agent-at-a-time restart gated on today's labs and orthostatics and coordinated with cardiology and nephrology. B advances the regimen, resuming the held agents at this primary-care visit gated on today's labs and adding spironolactone and empagliflozin to that advance. Both cardiology and nephrology defer a staged, parameter-gated restart to outpatient follow-up and decline a restart at this visit, so B's advance is the premature restart the chart forbids. A resists the central trap; B falls for it, and that difference decides it.

Justification: The grader names premature cardiorenal restart as the central scored failure, and the home blood-pressure readings as something that may be recorded as patient report but must not be used to resume held therapy. A holds all four agents and defers the restart to the specialists; B resumes them at this visit, even gated on labs. Outside item 1 the two plans are equivalent and clinically sound. The gap is confined to whether the held cardiorenal agents are resumed at this visit.

Prompt adherence: Both finalize the draft into a signable note, remove every DRAFT marker including the easily-missed running page footer, preserve the letterhead, demographics, and house formatting, add a signature block, and complete the open placeholders. Tie.

Correctness: The cardiorenal action is the sole correctness failure. B resumes renally and hemodynamically sensitive GDMT at the primary-care visit against both consultants' staged-restart-deferred position, even with lab gating; A holds those agents and defers. Every other clinical decision is correct in both: patient-reported BP, metformin held, prednisone without a numeric dose, anemia chronic and at baseline, spironolactone and empagliflozin surfaced as held, correctional insulin kept inpatient-only.

Completeness: Both cover every domain and add the same missing pieces (endocrinology follow-up, the two dropped held agents, the OT medication-safety plan, return precautions, the weekday-morning supervision gap). A runs longer (three pages) with more sourced detail; neither drops a domain.

Methodology: Both read the full chart, detect the two-copy draft and select the patient-reported version, trace doses to the MAR, medication reconciliation, and consults, and gate on pending labs. The difference is the restart judgment: A synthesizes the staged-restart-deferred guidance and holds all four; B reads the same guidance and advances the regimen anyway.

Quality and clarity: Comparable register and structure; both are problem-oriented, physician-ready notes with intact header and signature block. A is longer with more sourced detail; B is tighter. Neither document has formatting or readability problems.

Summary: A is much better because it resists the task's central designed trap, holding all four cardiorenal agents and deferring the staged restart to the specialists, while B resumes them at the primary-care visit against the chart's defer-to-outpatient guidance. On every other axis the two are equivalent and correct. The gap is the central restart action, which is why this is A3.

## Guardrails (must survive any edit)
1. The decider is item 1, hold vs advance. A holds all four and defers (clean 0.95); B advances/resumes the held agents at the visit (0.35). Do not claim both held.
2. Lab-gating a resume is still a resume = still the central trap.
3. B is the same trajectory as PL1's B; this is still a distinct comparison because the A differs. Flag for Abi: confirm a re-served B satisfies the three-distinct rule, since Studio selects the pair; the A trajectories differ across PL1 (0.68) and PL2 (0.95).
4. The gap word is "much better" = A3 = A++. Not A4 (B is a single central error in an otherwise complete, usable note, not multi-error or unusable). Not A2 (it is the central trap, not a secondary finding).
5. PL 2 of 3 required for KM05; one more on a different trajectory needed.

## Submit mechanics
Select A++ (two plus signs) -> paste justification (from "Preferred output: A" through "Summary") into Comments -> Submit Preference -> confirm entry shows in submission history -> run Preference Labels AutoQC.
